Hazardous Drug Compounding and USP <800> Compliance: A CSPT Exam Essential
As an aspiring CSPT Certified Compounded Sterile Preparation Technician, mastering the intricacies of hazardous drug (HD) compounding and USP <800> compliance is not just about passing your exam—it's about ensuring the safety of yourself, your colleagues, and your patients. In the dynamic world of sterile compounding, the proper handling of hazardous drugs is a paramount concern, reflecting the commitment to excellence and safety that defines certified professionals.
This mini-article, crafted specifically for PharmacyCert.com, will dive deep into USP <800> standards, outlining why this knowledge is indispensable for your Complete CSPT Certified Compounded Sterile Preparation Technician Guide and how it will appear on your certification exam. As of April 2026, adherence to these guidelines is more critical than ever, emphasizing the need for robust training and understanding among compounding personnel.
Key Concepts in Hazardous Drug Compounding and USP <800>
USP <800>, officially titled "Hazardous Drugs—Handling in Healthcare Settings," provides comprehensive standards for the safe handling of hazardous drugs to minimize the risk of exposure to healthcare personnel, patients, and the environment. For CSPTs involved in sterile compounding, understanding these concepts is foundational.
What Defines a Hazardous Drug?
The core of USP <800> begins with identifying what constitutes a hazardous drug. USP <800> references the National Institute for Occupational Safety and Health (NIOSH) List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings. Drugs are considered hazardous if they exhibit one or more of the following characteristics:
- Carcinogenicity (cancer-causing)
- Teratogenicity or other developmental toxicity (causing birth defects or developmental harm)
- Reproductive toxicity (adverse effects on reproductive capacity)
- Organ toxicity at low doses (damage to organs at small amounts)
- Genotoxicity (damage to DNA)
- New drugs that mimic existing hazardous drugs in structure or toxicity
It's crucial for CSPTs to be familiar with this list and understand that not all hazardous drugs are antineoplastic (cancer-fighting); many other common medications also fall under this classification.
Containment Strategy: Engineering Controls
USP <800> mandates a multi-layered approach to containment, primarily through specialized engineering controls:
- Containment Primary Engineering Control (C-PEC): This is the hood or isolator where actual compounding takes place. For sterile hazardous compounding, a C-PEC must be a Class II or III Biological Safety Cabinet (BSC) or a Compounding Aseptic Containment Isolator (CACI). Key features include:
- External exhaust (venting outside the building)
- Negative pressure (air flows into the C-PEC, not out)
- ISO Class 7 or better air quality (within the C-PEC)
It is vital to remember that traditional Laminar Airflow Workbenches (LAFWs) are never to be used for hazardous sterile compounding due to their positive pressure airflow.
- Containment Secondary Engineering Control (C-SEC): This refers to the room where the C-PEC is located. For sterile hazardous compounding, the C-SEC must be:
- ISO Class 7 air quality
- Negative pressure to adjacent non-HD areas (typically -0.01 to -0.03 inches of water column)
- Have at least 30 air changes per hour (ACPH)
- Be externally vented
This room is often called a "buffer room" or "cleanroom."
- Containment Segregated Compounding Area (C-SCA): For facilities that do not perform high-volume sterile hazardous compounding, a C-SCA may be used. It houses the C-PEC and must be:
- Externally vented
- Negative pressure
- Maintain at least 12 ACPH
- Does not need to meet ISO air quality requirements, but still requires appropriate garbing and cleaning. Preparations made here have a shorter beyond-use date (BUD).
Personal Protective Equipment (PPE)
Proper PPE is a non-negotiable aspect of HD handling. CSPTs must use specific PPE to prevent skin contact, inhalation, and ingestion of hazardous drugs. This includes:
- Gloves: Two pairs of chemotherapy-tested gloves (meeting ASTM D6978 standards) are required. The inner glove should be donned under the gown cuff, and the outer glove over the gown cuff. Gloves must be changed frequently (e.g., every 30 minutes, or immediately if torn or contaminated).
- Gowns: An impermeable, disposable gown made of polyethylene-coated polypropylene or other laminate material, that closes in the back, is required. Gowns must be changed per facility policy or immediately if contaminated, and never worn outside the compounding area.
- Head and Shoe Covers: Disposable head covers and two pairs of shoe covers are typically required.
- Respiratory Protection: Depending on the activity (e.g., spill cleanup, working outside a C-PEC, handling volatile HDs), a fit-tested N95 respirator or a powered air-purifying respirator (PAPR) may be required. Surgical masks offer no protection against HD aerosols or vapors.
- Eye and Face Protection: Goggles or a face shield should be worn when there is a risk of splashing or uncontrolled release of HDs.
Deactivation, Decontamination, Cleaning, and Disinfection (DDCD)
USP <800> outlines a specific four-step process for cleaning surfaces within HD compounding areas to ensure removal of residues:
- Deactivation: Inactivating hazardous drugs using an oxidizing agent (e.g., sodium hypochlorite or hydrogen peroxide).
- Decontamination: Removing hazardous drug residue using a neutralizing agent or solvent.
- Cleaning: Removing organic and inorganic material using a germicidal detergent.
- Disinfection: Killing microorganisms using a sterile alcohol (e.g., 70% isopropyl alcohol).
These steps must be performed in that sequence, with appropriate agents and PPE, and all waste must be disposed of as hazardous waste.
Other Critical Aspects
- Receiving and Storage: HDs must be clearly labeled and stored in an area that prevents contamination and accidental exposure. Antineoplastic HDs requiring manipulation must be stored in an externally vented, negative pressure room. Non-antineoplastic HDs and final dosage forms of antineoplastic HDs can be stored with other inventory but should be segregated.
- Spill Control: Facilities must have a comprehensive spill kit readily available and personnel trained in spill management specific to HDs.
- Medical Surveillance: Personnel regularly handling HDs should be enrolled in a medical surveillance program to monitor for potential adverse health effects.
- Training: All personnel handling HDs must receive initial and ongoing competency training.
How It Appears on the CSPT Exam
The CSPT exam will test your understanding of USP <800> in various formats. You can expect:
- Scenario-Based Questions: You might be presented with a situation (e.g., "A technician is preparing a chemotherapy infusion. Which PPE is required?") and asked to identify the correct procedure or equipment.
- Identification Questions: Recognizing proper engineering controls (e.g., identifying a C-PEC vs. a LAFW) or the components of a hazardous drug spill kit.
- Procedural Questions: Questions on the correct sequence for garbing, the DDCD process, or waste disposal.
- Definition Questions: Understanding terms like NIOSH list, negative pressure, or ISO classifications as they apply to HDs.
- Compliance Checks: Identifying violations of USP <800> standards or selecting the most compliant option.
"Mastering USP <800> is not just rote memorization; it's about internalizing the principles of containment and safety that underpin every step of hazardous drug compounding."
Expect questions that require you to differentiate between requirements for sterile non-hazardous compounding (USP <797>) and sterile hazardous compounding (USP <800>), particularly regarding engineering controls and PPE.
Study Tips for Mastering USP <800>
Preparing for the USP <800> section of the CSPT exam requires a focused approach:
- Understand the "Why": Don't just memorize rules; understand why each standard exists. Why is negative pressure critical? Why two pairs of gloves? This deeper understanding aids recall.
- Visual Learning: Study diagrams of C-PECs, C-SECs, and C-SCAs. Visualize the airflow patterns and pressure differentials.
- Flashcards for Definitions: Create flashcards for key terms like "NIOSH list," "C-PEC," "C-SEC," "Deactivation," "Decontamination," etc.
- Practice Scenarios: Work through practice questions that present real-world compounding scenarios. Our CSPT Certified Compounded Sterile Preparation Technician practice questions and free practice questions are excellent resources for this.
- PPE Layering: Memorize the correct order of donning and doffing PPE for hazardous drugs. Pay attention to the distinction between inner and outer gloves relative to the gown cuffs.
- DDCD Sequence: Clearly understand the four steps of deactivation, decontamination, cleaning, and disinfection, including the purpose of each and typical agents used.
- Focus on Differences: Pay special attention to what makes HD compounding unique compared to non-HD sterile compounding (e.g., external venting, negative pressure, specific PPE).
Common Mistakes to Watch Out For
Candidates often stumble on certain aspects of USP <800>. Be vigilant about these common pitfalls:
- Confusing Positive vs. Negative Pressure: Remember, hazardous compounding areas (C-PECs, C-SECs, C-SCAs) *always* require negative pressure relative to adjacent areas to contain hazardous aerosols. Positive pressure is for non-HD sterile compounding.
- Incorrect PPE Application: Forgetting the second pair of gloves, wearing the outer glove under the gown cuff, or not using chemotherapy-tested gloves are critical errors.
- Using the Wrong Engineering Control: Attempting to compound HDs in a LAFW or a non-vented isolator is a significant violation and a common exam distractor.
- Misunderstanding the DDCD Process: Mixing up the order of deactivation, decontamination, cleaning, and disinfection, or using inappropriate agents for each step.
- Neglecting External Venting: All C-PECs and C-SECs/C-SCAs for sterile HD compounding must be externally vented, not just recirculated within the facility.
- Ignoring NIOSH List: Not knowing that the NIOSH list is the primary reference for identifying hazardous drugs.
Quick Review / Summary
USP <800> compliance is a cornerstone of safe sterile hazardous drug compounding for CSPTs. Here's a quick recap of the essentials:
- Hazardous Drugs (HDs): Identified by the NIOSH list, based on toxicity characteristics.
- Engineering Controls:
- C-PEC (e.g., BSC, CACI): Externally vented, negative pressure, ISO Class 7.
- C-SEC (Buffer Room): ISO Class 7, negative pressure, externally vented, 30 ACPH.
- C-SCA (Segregated Compounding Area): Externally vented, negative pressure, 12 ACPH (no ISO requirement).
- PPE: Two pairs of chemotherapy-tested gloves, impermeable gown, head/shoe covers, and often respiratory/eye protection.
- DDCD Process: Deactivation → Decontamination → Cleaning → Disinfection.
- Key Principles: Containment, external venting, negative pressure, and rigorous personnel protection are paramount.
By thoroughly understanding these concepts, practicing with scenario-based questions, and avoiding common mistakes, you will be well-prepared to ace the USP <800> section of your CSPT Certified Compounded Sterile Preparation Technician exam and contribute to a safer pharmacy environment. Continue to utilize resources like PharmacyCert.com to solidify your knowledge and achieve certification.